Catalog No.
RHF09602
Species reactivity
Human, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IHC: 1:100-1:200
Target
WCH4, Aquaporin-4, Mercurial-insensitive water channel, AQP-4, MIWC, AQP4
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P55087
Applications
IHC
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1Z17
Nausea, Vertical Gaze Palsy, and Excessive Sleep: An Unusual Presentation of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder., PMID:40456289
MOGAD and NMOSD: insights on patients' radiological and laboratory findings from a single UAE center., PMID:39717684
Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder., PMID:39666920
Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies., PMID:39555058
A 32-year old lady who developed a complex generalized movement disorder in all four limbs after plasma exchange for myelitis., PMID:39067320
The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis., PMID:39053396
Socioeconomic burden of AQP4-antibody seropositive NMOSD: a nationwide registry-based study., PMID:39038947
Neuromyelitis Optica Spectrum Disorders (NMOSDs) Diagnosed After Surgery for the Ossification of the Posterior Longitudinal Ligament of the Cervical and Thoracic Spine: A Case Report., PMID:38966475
Impact of neuromyelitis optica spectrum disorder on employment and income in the United States., PMID:38374778
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore., PMID:37027019
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults., PMID:36515653
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina., PMID:36166174
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder., PMID:36070074
MR imaging in children with transverse myelitis and acquired demyelinating syndromes., PMID:35933757
COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD., PMID:35803084
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report., PMID:35585528
Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica., PMID:34782653
Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population., PMID:34715481
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases., PMID:34664709
Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study., PMID:34583213
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies., PMID:34530847
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis., PMID:34118585
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis., PMID:34048323
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort., PMID:33510701
Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis., PMID:33206944
An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)., PMID:32741562
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide., PMID:32670177
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics., PMID:32374571
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab., PMID:30913570
Neuromyelitis optica spectrum disorders: still evolving and broadening., PMID:30893099
Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options., PMID:30623348
[Characteristics of neuromyelitis optica spectrum disorder associated with the area postrema]., PMID:29534401
Neuromyelitis optica spectrum disorder associated with dengue virus infection., PMID:29475624
Mechanisms for lesion localization in neuromyelitis optica spectrum disorders., PMID:29465432
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease., PMID:29208041
Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: A comparison between Thai and American-Caucasian cohorts., PMID:29055481
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease., PMID:27951522
Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica., PMID:29114578
Demyelinating diseases in Asia., PMID:27070217
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO., PMID:26140280
[Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical]., PMID:25818784
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder., PMID:24192218
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders., PMID:23142960
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica., PMID:18945724
For research use only. Not for human or drug use.
